Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder.

MLA

Valiuliene, Giedre, et al. “Anti-Neuroinflammatory MicroRNA-146a-5p as a Potential Biomarker for Neuronavigation-Guided RTMS Therapy Success in Medication Resistant Depression Disorder.” Biomedicine & Pharmacotherapy, vol. 166, Oct. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115313.

APA

Valiuliene, G., Valiulis, V., Zentelyte, A., Dapsys, K., Germanavicius, A., & Navakauskiene, R. (2023). Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder. Biomedicine & Pharmacotherapy, 166, N.PAG. https://doi.org/10.1016/j.biopha.2023.115313

Chicago

Valiuliene, Giedre, Vladas Valiulis, Aiste Zentelyte, Kastytis Dapsys, Arunas Germanavicius, and Ruta Navakauskiene. 2023. “Anti-Neuroinflammatory MicroRNA-146a-5p as a Potential Biomarker for Neuronavigation-Guided RTMS Therapy Success in Medication Resistant Depression Disorder.” Biomedicine & Pharmacotherapy 166 (October): N.PAG. doi:10.1016/j.biopha.2023.115313.